Samuel M Kim1, Harsimran S Singh1, Jillian Nati1, Jonathan N Ginns2. 1. Division of Cardiology, Department of Medicine, NewYork Presbyterian Hospital-Weill Cornell Medicine, 520 E 70th St, Starr 4, New York, NY, 10021, USA. 2. Division of Cardiology, Department of Medicine, NewYork Presbyterian Hospital-Weill Cornell Medicine, 520 E 70th St, Starr 4, New York, NY, 10021, USA. jog9097@med.cornell.edu.
Abstract
PURPOSE OF REVIEW: The goal of this review is to cover the epidemiology of tricuspid regurgitation (TR), anatomy of the tricuspid valve (TV), and the mechanisms and modern treatment of TR. The focus will be on the role of echocardiography, cardiac CT, and MRI to determine the mechanism, severity, and management strategies of TR. RECENT FINDINGS: The evaluation and management of TR is a rapidly growing field with significant advances in both imaging and interventions. Important advances have been made to understand TV anatomy and physiology in 3D echo, CT, and MRI. Additional understanding of the abnormal outcomes in both primary TR and secondary TR have been appreciated. Multiple transcatheter devices have reached the stage of early trials in high surgical risk cohorts with favorable initial findings. TR is a significant cardiovascular problem and vastly undertreated in the present era. There has been tremendous growth in knowledge of mechanisms of TR, its prognostic implications, timing of intervention, and development of novel treatment strategies. Multimodality imaging plays a key role in evaluation and treatment of this condition.
PURPOSE OF REVIEW: The goal of this review is to cover the epidemiology of tricuspid regurgitation (TR), anatomy of the tricuspid valve (TV), and the mechanisms and modern treatment of TR. The focus will be on the role of echocardiography, cardiac CT, and MRI to determine the mechanism, severity, and management strategies of TR. RECENT FINDINGS: The evaluation and management of TR is a rapidly growing field with significant advances in both imaging and interventions. Important advances have been made to understand TV anatomy and physiology in 3D echo, CT, and MRI. Additional understanding of the abnormal outcomes in both primary TR and secondary TR have been appreciated. Multiple transcatheter devices have reached the stage of early trials in high surgical risk cohorts with favorable initial findings. TR is a significant cardiovascular problem and vastly undertreated in the present era. There has been tremendous growth in knowledge of mechanisms of TR, its prognostic implications, timing of intervention, and development of novel treatment strategies. Multimodality imaging plays a key role in evaluation and treatment of this condition.
Authors: Julius I Ejiofor; Robert C Neely; Maroun Yammine; Siobhan McGurk; Tsuyoshi Kaneko; Marzia Leacche; Lawrence H Cohn; Prem S Shekar Journal: Ann Cardiothorac Surg Date: 2017-05
Authors: Alexander Lauten; Hans R Figulla; Axel Unbehaun; Neil Fam; Joachim Schofer; Torsten Doenst; Joerg Hausleiter; Marcus Franz; Christian Jung; Henryk Dreger; David Leistner; Brunilda Alushi; Anja Stundl; Ulf Landmesser; Volkmar Falk; Karl Stangl; Michael Laule Journal: Circ Cardiovasc Interv Date: 2018-02 Impact factor: 6.546
Authors: Gidon Perlman; Fabien Praz; Rishi Puri; Hadass Ofek; Jian Ye; Francois Philippon; Thierry Carrel; Philippe Pibarot; Adrian Attinger; Nay Min Htun; Danny Dvir; Robert Moss; Francisco Campelo-Parada; Elisabeth Bédard; David Reineke; Aris Moschovitis; Sandra Lauck; Philipp Blanke; Jonathon Leipsic; Stephan Windecker; Josep Rodés-Cabau; John Webb Journal: JACC Cardiovasc Interv Date: 2017-08-02 Impact factor: 11.195